CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5,197 enrolled
Drug / intervention
Nasopharyngeal swab +3 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04578509
NCT04578509N/ACompleted

Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva (COVID-19)

Assistance Publique - Hôpitaux de Paris·observational·Posted Oct 8, 2020·Updated Mar 9, 2026

In Brief

An observational study evaluating Nasopharyngeal swab, Saliva sample, and 2 other interventions for SARS-CoV-2 Infection and COVID-19. Completed, enrolled 5,197 participants across 1 site.

Detailed Summary

The investigators hypothesize that detection of SARS-CoV2 on saliva samples will increase the performance of the screening program compared to the reference strategy (RT-PCR on a nasopharyngeal swab).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 8, 2020
Enrollment StartOct 19, 2020
Primary CompletionJun 9, 2021
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 5.7 years ago

Interventions

Nasopharyngeal swabother

Research of SARS-CoV-2 infection in nasopharyngeal swab by RT-PCR and by antigenic test

Saliva sampleother

Research of SARS-CoV-2 infection in saliva samples by RT-PCR and by new detection approach

axillary sweat sampleother

Research of volatile olfactory compounds of SARS-CoV-2 infection by canine detection on axillary sweat.

Data collectionother

Demographics, symptoms, medical history, acceptability of specimen, consumption in precedents hours are collected